CCL7 and acute kidney injury: Therefore, to understand whether kidney B cell–derived CCL7 may play a role in AKI by influencing myeloid cell recruitment, we administered a polyclonal CCL7-blocking Ab at the time of AKI induction (Fig. 4D).